Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Fibrinolysis

Citations 1-10 of 140 total displayed.

Most recent content (23 Jun 2009):

Interventional Cardiology
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation 119: 3101 -3109; published online before print as doi:10.1161/CIRCULATIONAHA.108.793745 [Abstract] [Full text]  

Past content (since Jan 1999):

Articles
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment–Elevation Myocardial Infarction. Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
Thao Huynh, Stephane Perron, Jennifer O'Loughlin, Lawrence Joseph, Michel Labrecque, Jack V. Tu, and Pierre Théroux
Circulation published June 8, 2009, doi:10.1161/CIRCULATIONAHA.108.793745 [Abstract]  

Hypertension
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
Chiara Giannarelli, Agostino Virdis, Ferdinando De Negri, Armando Magagna, Emiliano Duranti, Antonio Salvetti, and Stefano Taddei
Circulation 119: 1625 -1633; published online before print as doi:10.1161/CIRCULATIONAHA.108.782482 [Abstract] [Full text]  

Articles
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
Chiara Giannarelli, Agostino Virdis, Ferdinando De Negri, Armando Magagna, Emiliano Duranti, Antonio Salvetti, and Stefano Taddei
Circulation published March 16, 2009, doi:10.1161/CIRCULATIONAHA.108.782482 [Abstract]  

Controversies in Cardiovascular Medicine
Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
Paul W. Armstrong, Cynthia M. Westerhout, and Robert C. Welsh
Circulation 2009; 119: 1293-1303, doi:10.1161/CIRCULATIONAHA.108.796383 [Full text]  

Controversies in Cardiovascular Medicine
Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction
Peter Bogaty
Circulation 2009; 119: 1304-1310, doi:10.1161/CIRCULATIONAHA.107.750679 [Full text]  

Coronary Heart Disease
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation 118: 2783 -2789; published online before print as doi:10.1161/CIRCULATIONAHA.108.776690 [Abstract] [Full text]  

Articles
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
Jaume Figueras, Oscar Alcalde, José A. Barrabés, Vicens Serra, Joan Alguersuari, Josefa Cortadellas, and Rosa-Maria Lidón
Circulation published December 8, 2008, doi:10.1161/CIRCULATIONAHA.108.776690 [Abstract]  

Images in Cardiovascular Medicine
Regression of Thrombus and Electrocardiographic Changes With Thrombolytic Therapy in Acute Massive Pulmonary Embolism
Evin Bozcali and Yildiray Tutpinar
Circulation 2008; 118: 2207-2208, doi:10.1161/CIRCULATIONAHA.108.780601 [Full text]  

Editorials
A Novel Role for Tissue-Type Plasminogen Activator: Prevention of Thromboembolic Occlusion
David J. Schneider and Burton E. Sobel
Circulation 2008; 118: 1408-1409, doi:10.1161/CIRCULATIONAHA.108.807586 [Full text]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

* Subspecialty Collections Home

* Show  Fibrinolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors